Anja van Brabant Smith

ORCID: 0000-0003-3145-6599
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA Interference and Gene Delivery
  • CRISPR and Genetic Engineering
  • Advanced biosensing and bioanalysis techniques
  • RNA and protein synthesis mechanisms
  • Molecular Biology Techniques and Applications
  • RNA regulation and disease
  • Virus-based gene therapy research
  • Single-cell and spatial transcriptomics
  • RNA Research and Splicing
  • Mass Spectrometry Techniques and Applications
  • Innovation and Socioeconomic Development
  • DNA and Nucleic Acid Chemistry
  • CAR-T cell therapy research
  • Estrogen and related hormone effects
  • Diabetes and associated disorders
  • Immunotherapy and Immune Responses
  • Animal Genetics and Reproduction
  • Cancer, Hypoxia, and Metabolism
  • Pluripotent Stem Cells Research

Horizon Discovery Group (United States)
2017-2022

University of Colorado Boulder
2022

General Electric (Spain)
2015

Thermo Fisher Scientific (Israel)
2012-2014

New York State Department of Health
1978

Delivery of siRNA is a key hurdle to realizing the therapeutic promise RNAi. By targeting internalizing cell surface antigens, antibody–siRNA complexes provide possible solution. However, initial reports relied on non-specific charged interactions and have not been broadly applicable. To assess improve this delivery method, we built an industrial platform antibodies called THIOMABs, engineered enable precise covalent coupling siRNAs. We report that such generates monomeric conjugates (ARCs)...

10.1093/nar/gku1362 article EN cc-by Nucleic Acids Research 2014-12-30

The discovery that the bacterial clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) acquired immune system can be utilized to create double-strand breaks (DSBs) in eukaryotic genomes has resulted ability genomic changes more easily than with other genome engineering techniques. While there is significant potential for CRISPR-Cas9 advance basic and applied research, several unknowns remain, including specificity of RNA-directed DNA cleavage...

10.1016/j.jbiotec.2015.06.427 article EN cc-by-nc-nd Journal of Biotechnology 2015-07-18

Since its initial application in mammalian cells, CRISPR-Cas9 has rapidly become a preferred method for genome engineering experiments. The Cas9 nuclease is targeted to genomic DNA using guide RNAs (gRNA), either as the native dual RNA system consisting of DNA-targeting CRISPR (crRNA) and trans-activating crRNA (tracrRNA), or chimeric single (sgRNA). Entirely DNA-free systems protein mRNA chemically synthesized gRNAs allow transient expression components, thereby reducing potential...

10.1371/journal.pone.0188593 article EN cc-by PLoS ONE 2017-11-27

MAD7 is an engineered class 2 type V-A CRISPR-Cas (Cas12a/Cpf1) system isolated from Eubacterium rectale. Analogous to Cas9, it RNA-guided nuclease with demonstrated gene editing activity in Escherichia coli and yeast cells. Here, we report that capable of generating indels fluorescent tagging endogenous genes human HCT116 U2OS cancer cell lines, respectively. In addition, highly proficient indels, small DNA insertions (23 bases), larger integrations ranging 1 14 kb size mouse rat embryos,...

10.1089/crispr.2019.0068 article EN cc-by-nc The CRISPR Journal 2020-04-01

Abstract The potent tumor promoter tetradecanoyl phorbol acetate (TPA) induces early changes in ion movements analogous to those induced by prostaglandins E 1 and F 2α . Among the earliest TPA is a significant increase 32 P i incorporation within 15 minutes incubation of (10 −8 −10 −6 M) with post‐confluent Swiss 3T3 mouse embryonic fibroblasts. Similarly, active ester homolog 4‐;β‐;OH didecanoate but not inactive stereoisomeric 4‐β‐OH stimulated incorporation. Also, at above concentrations...

10.1002/jcp.1040950306 article EN Journal of Cellular Physiology 1978-06-01

RNAi screening using pooled shRNA libraries is a valuable tool for identifying genetic regulators of biological processes. However, successful screen, it imperative to thoroughly optimize experimental conditions obtain reproducible data. Here we performed viability screens with library ∼10 000 shRNAs at two different fold representations (100- and 500-fold transduction) report the reproducibility abundance changes between replicates determined by microarray next generation sequencing...

10.1371/journal.pone.0042341 article EN cc-by PLoS ONE 2012-08-01

While the use of RNA interference (RNAi) in molecular biology and functional genomics is a well-established technology, vivo applications synthetic short interfering RNAs (siRNAs) require chemical modifications. We recently found that amides as non-ionic replacements for phosphodiesters may be useful modifications optimization siRNAs. Herein, we report comprehensive study systematic replacement single phosphate with an amide linkage throughout guide strand The results show are surprisingly...

10.1093/nar/gkx558 article EN cc-by-nc Nucleic Acids Research 2017-06-18

Potential in vivo applications of RNA interference (RNAi) require suppression various off-target activities. Herein, we report that replacement a single phosphate linkage between the first and second nucleosides passenger strand with an amide almost completely abolished its undesired activity restored desired guide strands had been compromised by unfavorable modifications. Molecular modeling suggested observed effect was most likely due to suppressed loading amide-modified into Ago2 caused...

10.1021/acschembio.7b01012 article EN ACS Chemical Biology 2018-01-03

The CRISPR-Cas9 system has been utilized for large-scale, loss-of-function screens mainly using lentiviral pooled formats and cell-survival phenotypic assays. Screening in an arrayed format expands the types of readouts that can be used to now include high-content, morphology-based assays, with recent availability synthetic crRNA libraries, new studies are emerging. Here, we use a cell cycle reporter line perform arrayed, crRNA:tracrRNA screen targeting 169 genes (>600 crRNAs) high content...

10.1016/j.jbiotec.2017.04.017 article EN cc-by-nc-nd Journal of Biotechnology 2017-04-23

The CRISPR-Cas9 gene editing system requires Cas9 endonuclease and guide RNAs (either the natural dual RNA consisting of crRNA tracrRNA or a chimeric single RNA) that direct site-specific double-stranded DNA cleavage. This communication describes click ligation approach uses alkyne-azide cycloaddition to generate triazole-linked (sgRNA). conjugated sgRNA shows efficient comparable genome activity unmodified constructs.

10.1002/cbic.201600320 article EN cc-by-nc-nd ChemBioChem 2016-07-21

While CRISPR interference (CRISPRi) systems have been widely implemented in pooled lentiviral screening, there has limited use with synthetic guide RNAs for the complex phenotypic readouts enabled by experiments arrayed format. Here we describe a novel deactivated Cas9 fusion protein, dCas9-SALL1-SDS3, which produces greater target gene repression than first or second generation CRISPRi when used chemically modified single (sgRNAs), while exhibiting high specificity. We show that...

10.1089/crispr.2022.0056 article EN cc-by The CRISPR Journal 2022-10-18

RNA interference screening using pooled, short hairpin (shRNA) is a powerful, high-throughput tool for determining the biological relevance of genes phenotype. Assessing an shRNA pooled screen's performance difficult in practice; one can estimate only by reproducibility as proxy power or employing large number validated positive and negative controls. Here, we develop open-source software tool, Power Decoder simulator, generating experiments silico that be used to statistical power. Using...

10.1177/1087057115576715 article EN cc-by-nc-nd SLAS DISCOVERY 2015-03-17

Abstract Cell culture has long been essential for preclinical modeling of human development and disease. However, conventional two‐dimensional (2D) cell fails to faithfully model the complexity found in vivo, novel drug candidates that show promising results 2D models often do not translate clinic. More recently, three‐dimensional (3D) have gained popularity owing their greater physiological relevance vivo biology. In particular, 3D spheroid are becoming widely used due ability mimic solid...

10.1002/cpz1.1121 article EN cc-by-nc-nd Current Protocols 2024-09-01

While the CRISPR-Cas9 system from S. pyogenes is a powerful genome engineering tool, additional programmed nucleases would enable added flexibility in targeting space and multiplexing. Here, we characterized L. gasseri found that it has modest activity cell-free lysate assay but no mammalian cells even when altering promoter, position of tag sequences NLS, length crRNA:tracrRNA. In tested over 400 sequential crRNA target Lga Cas9 PAM NNGA/NDRA, different than NTAA predicted native bacterial...

10.1371/journal.pone.0192181 article EN cc-by PLoS ONE 2018-02-02

Abstract Gene editing technologies hold promise for enabling the next generation of adoptive cellular therapies. Conventional gene platforms that rely on nuclease activity, such as Clustered regularly interspaced short palindromic repeats-CRISPR associated protein 9 (CRISPR-Cas9), allow efficient introduction genetic modifications; however, these modifications occur via DNA double-strand breaks (DSBs) and can lead to unwanted genomic alterations genotoxicity. Here, we apply novel modular RNA...

10.1101/2023.06.20.545315 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2023-06-21

Abstract Functional gene analysis studies have been empowered by development of CRISPR-Cas9 knockout tools, however the system has also adapted for inhibition or activation transcription. A nuclease-deactivated Cas9 (dCas9) can be fused to various effector domains produce an RNA-guided transcription factor either (CRISPRi) (CRISPRa) target genes. For overexpression studies, CRISPRa holds significant advantages over traditional vector-based expression, because genes are upregulated from their...

10.1158/1538-7445.am2019-2761 article EN Cancer Research 2019-07-01

Functional gene analysis studies have been empowered by development of CRISPR-Cas9 knockout tools, however the system has also adapted for inhibition or activation transcription. A nuclease-deactivated Cas9 (dCas9) can be fused to various effector domains produce an RNA-guided transcription factor either (CRISPRi) (CRISPRa) target genes. For overexpression studies, CRISPRa holds significant advantages over traditional vector-based expression, because genes are upregulated from their native...

10.1158/1538-7445.sabcs18-2761 article EN Cancer Chemistry 2019-07-01
Coming Soon ...